IntelGenx Receives USPTO Notice of Allowance for Oral Film Dosage Form Technology Patent
SAINT LAURENT, QUEBEC–(Marketwired – June 27, 2017) – IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company primarily [...]